AdjournmentThursday, 16 April 2026

Improving awareness, diagnosis and outcomes for neuroendocrine cancer

End-of-day debate on a single topic

Dr Scott Arthur is raising awareness and discussing improvements needed for neuroendocrine cancer (a rare group of cancers affecting hormone-producing cells). The adjournment debate focuses on better public awareness, faster diagnosis, and improved treatment outcomes for patients with this often under-recognised condition.

Neuroendocrine cancers are rare but serious conditions often diagnosed late because they are poorly understood by patients and healthcare professionals. Improving awareness and diagnostic pathways could lead to earlier detection and better survival rates, benefiting a small but vulnerable patient population across the UK.

Securing MP

Related business

Upcoming similar business

Past similar business

Upcoming on related topics

Past on related topics